Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet;
403(10442): 2416-2425, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet;
403(10442): 2405-2415, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763154
3.
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.
Hum Mol Genet;
25(24): 5490-5499, 2016 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27798103
4.
Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
BJU Int;
111(7): 1148-55, 2013 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22985493
5.
Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
BJU Int;
112(5): 666-73, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23320731
6.
Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.
Am Soc Clin Oncol Educ Book;
2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23714454